Registration of securities issued in business combination transactions

Balance Sheets (Supera Pharmaceuticals, Inc.)

v3.20.4
Balance Sheets (Supera Pharmaceuticals, Inc.) - USD ($)
Dec. 31, 2020
Dec. 31, 2019
Current Assets:    
Cash $ 18,617,955 $ 517,444
Total Assets 36,842,761 10,884,935
LIABILITIES AND STOCKHOLDER'S DEFICIT    
Trade accounts payable 569,999 599,306
Total Current Liabilities 2,263,295 1,529,765
Total Liabilities 2,263,295 1,529,765
Stockholder's Deficit    
Common stock value 171,598,681 128,920,414
Accumulated Deficit (137,163,739) (119,583,130)
Total Shareholders' Equity 34,579,466 9,355,170
Total Liabilities and Stockholder's Deficit 36,842,761 10,884,935
Supera Pharmaceuticals, Inc. [Member]    
Current Assets:    
Cash 14,551 2,476
Due from affiliate 24,600
Total Assets 39,151 2,476
LIABILITIES AND STOCKHOLDER'S DEFICIT    
Trade accounts payable 556,781 145,494
Due to affiliate 14,849
Paycheck Protection Program Loan 16,600
Total Current Liabilities 573,381 160,343
Related party line of credit 599,747 444,516
Related party interest payable 29,628 2,706
Total Liabilities 1,202,756 607,565
Stockholder's Deficit    
Common stock value
Additional paid-in capital
Accumulated Deficit (1,163,605) (605,089)
Total Shareholders' Equity (1,163,605) (605,089)
Total Liabilities and Stockholder's Deficit $ 39,151 $ 2,476